Emergence of Linezolid Resistance in the Vancomycin-Resistant Enterococcus faecium Multilocus Sequence Typing C1 Epidemic Lineage-Reference-Cited by-同舟云学术

Emergence of Linezolid Resistance in the Vancomycin-Resistant Enterococcus faecium Multilocus Sequence Typing C1 Epidemic Lineage

Published:2006-03 Issue:3 Volume:44 Page:1153-1155
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Bonora Maria Grazia¹,Solbiati Maurizio²,Stepan Erminia³,Zorzi Antonella³,Luzzani Aldo⁴,Catania Maria Rosaria⁵,Fontana Roberta¹³

Affiliation:

1. Dipartimento di Patologia, Sezione di Microbiologia, Università di Verona

2. Osservatorio Epidemiologico, Azienda Ospedaliera di Verona

3. Servizio di Microbiologia, Immunologia e Virologia, Azienda Ospedaliera di Verona

4. Unità di Rianimazione e Terapia Intensiva, Azienda Ospedaliera di Verona, Verona, Italy

5. Dipartimento di Biologia Cellulare e Molecolare, Università di Napoli Federico II, Napoli, Italy

Abstract

ABSTRACT A relatively high rate of vancomycin-resistant Enterococcus faecium not susceptible to linezolid was observed in intensive care unit patients. Linezolid-resistant isolates carried the G2576T mutation in the 23S rRNA gene, belonged to different clones, and shared the same allelic profile, which clusters in the C1 multilocus sequence typing epidemic lineage.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.44.3.1153-1155.2006

Reference14 articles.

1. Bonora, M. G., M. Ligozzi, M. De Fatima, L. Bragagnolo, A. Goglio, G. C. Guazzotti, and R. Fontana. 2004. Vancomycin-resistant Enterococcus faecium isolates causing hospital outbreaks in northern Italy belong to the multilocus sequence typing C1 lineage. Microb. Drug Resist.10:114-123.

2. Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing: 14th informational supplement. Approved standard M100-S13. Clinical and Laboratory Standards Institute Wayne Pa.

3. Garner, J. S., W. R. Jarvis, T. G. Emori, T. C. Horan, and J. M. Hughes. 1988. CDC definitions for nosocomial infections, 1988. Am. J. Infect. Control16:128-140.

4. Gonzales, R. D., P. C. Schreckenberger, M. B. Graham, S. Kelkar, K. DenBesten, and J. P. Quinn. 2001. Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid. Lancet357:1179.

5. Herrero, I. A., N. C. Issa, and R. Patel. 2002. Nosocomial spread of linezolid-resistant vancomycin-resistant Enterococcus faecium. N. Engl. J. Med.346:867-869.

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emergence of OptrA Gene Mediated Linezolid Resistance among Enterococcus Faecium: A Pilot Study from a Tertiary Care Hospital, India;INT J MOL CELL MED;2024

2. Synergistic properties of linezolid against Enterococcus spp. isolates: a systematic review from in vitro studies;European Journal of Clinical Microbiology & Infectious Diseases;2023-11-17

3. Trends in the Incidence and Antibiotic Resistance of Enterococcal Bloodstream Isolates: A 7-Year Retrospective Multicenter Epidemiological Study in Italy;Microbial Drug Resistance;2021-04-01

4. Role of linezolid combination therapy for serious infections: review of the current evidence;European Journal of Clinical Microbiology & Infectious Diseases;2020-01-02

5. The ongoing challenge of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Europe: an epidemiological analysis of bloodstream infections;Emerging Microbes & Infections;2020-01-01